Amanote Research
Register
Sign In
Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients
Drugs in Context
- United Kingdom
doi 10.7573/dic.212585
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Pharmacology
Date
December 2, 2019
Authors
Michael E Røder
Publisher
BioExcel
Related search
Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
Clinical Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes
Vascular Health and Risk Management
Pdb87 - A Cost-Of-Control Analysis: Once-Weekly Semaglutide Reduces Cost of Reaching Treatment Targets in Patients With Type 2 Diabetes Mellitus in Norway
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Variables Associated With Depression in Patients With Type 2 Diabetes
Revista da Associacao Medica Brasileira
Medicine
Semaglutide: A New GLP‐1 Analogue for Type 2 Diabetes
Prescriber
Pharmacology
1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Clinical Characteristics in Patients With Type 2 Diabetes Mellitus: A Cohort Study
Endocrine Abstracts
Pmd177 - Patient Preferences and Health State Utilities Associated With Dulaglutide and Semaglutide Injection Devices Among Patients With Type 2 Diabetes in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Multifactorial Treatment Increases Endothelial Progenitor Cells in Patients With Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
